Beijing ACCB Biotech Overview
- Year Founded
-
2004

- Status
-
Private
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
9
- Investments
-
1
Beijing ACCB Biotech General Information
Description
Developer of cancer detection and molecular diagnostic technologies created to provide advanced and reliable molecular diagnostic products for precision medicine. The company develops and commercializes in vitro diagnostic kits, clinical diagnostic tests for cancer screening, early-stage cancer detection, prognosis evaluation, precision cancer therapies and re-occurrence monitoring and polymerase chain reaction (PCR) kits to detect gene mutation, amplification, gene fusion, expression and polymorphisms, using in-house research laboratories and certified processes, enabling patients with individualized treatment plans.
Contact Information
Website
www.accb.com.cnCorporate Office
- 1555 Office Building
- Hotel Nikko New Century
- Beijing, 100048
- China
Corporate Office
- 1555 Office Building
- Hotel Nikko New Century
- Beijing, 100048
- China
Beijing ACCB Biotech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Beijing ACCB Biotech Patents
Beijing ACCB Biotech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180112271-A1 | Kit for detecting pik3ca gene mutation | Inactive | 29-May-2014 | ||
EP-3150717-A1 | Pik3ca gene mutation detection kit | Inactive | 29-May-2014 | ||
EP-3150717-A4 | Pik3ca gene mutation detection kit | Inactive | 29-May-2014 | ||
US-20130217115-A1 | Plasmid standard for use in quantitative assays using fluorescent quantitative pcr | Inactive | 18-Oct-2010 | ||
EP-2540838-A1 | Kit for quantitative detection of braf mutation | Inactive | 24-Feb-2010 | C12Q1/6886 |
Beijing ACCB Biotech Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Beijing ACCB Biotech Investments (1)
Beijing ACCB Biotech’s most recent deal was a Seed Round with Cordmagic. The deal was made on 21-Mar-2019.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Cordmagic | 21-Mar-2019 | Seed Round | Personal Products |
Beijing ACCB Biotech FAQs
-
When was Beijing ACCB Biotech founded?
Beijing ACCB Biotech was founded in 2004.
-
Where is Beijing ACCB Biotech headquartered?
Beijing ACCB Biotech is headquartered in Beijing, China.
-
What industry is Beijing ACCB Biotech in?
Beijing ACCB Biotech’s primary industry is Diagnostic Equipment.
-
Is Beijing ACCB Biotech a private or public company?
Beijing ACCB Biotech is a Private company.
-
What is Beijing ACCB Biotech’s current revenue?
The current revenue for Beijing ACCB Biotech is
. -
Who are Beijing ACCB Biotech’s investors?
PICC TusHoldings Fund, SummitView Capital, Tsinghua Holdings, and TusHoldings have invested in Beijing ACCB Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »